Capecitabine and temozolomide or temozolomide alone in patients with atypical carcinoids
2025 · Endocrine · 2 citations
https://doi.org/10.1007/s12020-025-04171-5
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
11
Papers
91
Citations
5
h-index
4
i10-index
Linda Galvani is an academic researcher from University of Bologna. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Lung Cancer Research Studies & Cervical Cancer and HPV Research. The author has an h-index of 5, co-authored 10 publications.
Click to start Chat